The mifepristone case, FDA v. Alliance for Hippocratic Medicine, attracted a lot of national attention not only because of its implications for reproductive rights, but also because of the question related to the FDA's regulatory power. On June 13, 2024, the decision of the Supreme Court of the United States resulted in access to mifepristone, an abortion medication, remaining unchanged, but the decision was based on a procedural issue rather than an effort to protect reproductive rights.

Back in 2022, the abortion rights that were once federally protected under Roe v. Wade were overturned by the Court in Dobbs v. Jackson Women's Health Organization. Determining that the Constitution did not confer a right to an abortion, the Court ruled that the power to regulate abortion should return to the states. Since that time, there have been a host of new laws in various states, some protecting the right to abortion, some instituting limitations, and some banning abortion entirely.